- Home
- AVIR vs AXG Comparison
AVIR vs AXG Comparison
Compare AVIR & AXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVIR | AXG |
|---|---|---|
| Founded | 2012 | 2021 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 413.1M | 361.1M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | AVIR | AXG |
|---|---|---|
| Price | $4.17 | $0.05 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | 277.8K | ★ 6.7M |
| Earning Date | 11-11-2026 | 08-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.87 | $0.05 |
| 52 Week High | $6.45 | $4.75 |
Technical Indicators
Market Signals| Indicator | AVIR | AXG |
|---|---|---|
| Relative Strength Index (RSI) | 30.76 | 11.25 |
| Support Level | $4.06 | N/A |
| Resistance Level | $4.46 | $0.12 |
| Average True Range (ATR) | 0.25 | 0.01 |
| MACD | -0.08 | 0.08 |
| Stochastic Oscillator | 17.69 | 7.12 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
About AXG Solowin Holdings Class A Ordinary Share
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Digital Asset Tokens, and AI Tokens. It generates maximum revenue from AI Tokens segment.